Test Code CRU Chromium, 24 Hour, Urine
Reporting Name
Chromium, 24 Hr, UUseful For
Screening for occupational exposure to chromium
Monitoring metallic prosthetic implant wear
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
UrineOrdering Guidance
High concentrations of gadolinium and iodine are known to interfere with most metal tests. If either gadolinium- or iodine-containing contrast media has been administered, a specimen should not be collected for 96 hours.
Specimen Required
Supplies: Urine Tubes, 10 mL (T068)
Collection Container/Tube: Clean, plastic urine container with no metal cap or glued insert
Submission Container/Tube: Plastic, 10-mL urine tube or clean, plastic aliquot container with no metal cap or glued insert
Specimen Volume: 0.5 mL
Collection Instructions:
1. Collect urine for 24 hours.
2. Refrigerate specimen within 4 hours of completion of 24-hour collection.
3. See Metals Analysis Specimen Collection and Transport for complete instructions.
Additional Information:
1. 24-Hour volume is required.
2. See Urine Preservatives-Collection and Transportation for 24-Hour Urine Specimens for multiple collections.
Specimen Minimum Volume
0.3 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Refrigerated (preferred) | 28 days | |
Ambient | 28 days | ||
Frozen | 28 days |
Special Instructions
Reference Values
0-17 years: Not established
≥18 years: 0.1-1.2 mcg/24 hours
Day(s) Performed
Tuesday, Wednesday, Friday
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82495
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CRU | Chromium, 24 Hr, U | 5624-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
8593 | Chromium, 24 Hr, U | 5624-2 |
TM44 | Collection Duration | 13362-9 |
VL42 | Urine Volume | 3167-4 |
Interpretation
Chromium is principally excreted in the urine. Urine levels correlate with exposure. Results greater than the reference range indicate either recent exposure to chromium or specimen contamination during collection.
Prosthesis wear is known to result in increased circulating concentration of metal ions. Modest increase (8-16 mcg/24 hour) in urine chromium concentration is likely to be associated with a prosthetic device in good condition. Urine concentrations greater than 20 mcg/24 hours in a patient with chromium-based implant suggest significant prosthesis wear. Increased urine trace element concentrations in the absence of corroborating clinical information do not independently predict prosthesis wear or failure.
The National Institute for Occupational Safety and Health draft document on occupational exposure reviews the data supporting use of urine to assess chromium exposure. They recommend a Biological Exposure Index of 10 mcg/g creatinine and 30 mcg/g creatinine for the increase in urinary chromium concentrations during a work shift and at the end of shift at the end of the workweek, respectively. A test for this specific purpose (CRUO / Chromium Occupational Exposure, Random, Urine) is available.
Clinical Reference
1. Vincent JB. Elucidating a biological role for chromium at a molecular level. Acc Chem Res. 2000;33(7):503-510
2. Centers for Disease Control and Prevention, The National Institute for Occupational Safety and Health (NIOSH): Criteria for a Recommended Standard for an Occupational Exposure to Hexavalent Chromium. September 2013. Accessed July 22, 2022. CDC; Available at www.cdc.gov/niosh/docs/2013-128/pdfs/2013_128.pdf
3. Keegan GM, Learmonth ID, Case CP. A systematic comparison of the actual, potential, and theoretical health effects of cobalt and chromium exposures from industry and surgical implants. Crit Rev Toxicol. 2008;38:645-674
4. Sodi R. Vitamins and trace elements. In: Rifai N, Chiu RWK, Young I, eds: Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier; 2023:chap 39
5. Eliaz N. Corrosion of metallic biomaterials: A review. Materials (Basel). 2019;12(3):407. doi: 10.3390/ma12030407
6. US Food and Drug Administration. Information about Soft Tissue Imaging and Metal Ion Testing. FDA; Updated March 15, 2019. Accessed March 2, 2021. Available at www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm331971.htm
Report Available
1 to 4 daysMethod Name
Inductively Coupled Plasma-Mass Spectrometry (ICP-MS)